Theravance Biopharma, Inc.
CEO, Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Eran Broshy was last confirmed as CEO and Board Member at Theravance Biopharma, Inc. in a filing dated April 10, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Theravance Biopharma, Inc.
CEO
Proxy statement
Start not stated–2025-04-10
Last confirmed by a filing; no departure on record
Theravance Biopharma, Inc.
Board Member
Proxy statement
Start not stated–2025-04-10
Last confirmed by a filing; no departure on record
Recorded roles and call appearances connecting this person to public companies.
Theravance Biopharma, Inc.
CEO, Board Member
No call appearances or filed executive changes recorded yet.